- 4.2Impact Factor
- 7.7CiteScore
- 20 daysTime to First Decision
Current Updates on Multidrug-Resistant Gram-Negative Bacterial Infections
This special issue belongs to the section “Antimicrobial Agents and Resistance“.
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) is one of the top 10 global public health challenges and ranks among the three highest-priority health threats, resulting in an estimated 1.27 million deaths worldwide each year.
Stemming from the multiple resistance mechanisms of pathogens, multidrug-resistant Gram-negative bacterial infections lead to significant morbidity and mortality worldwide. Certain pathogens, such as carbapenem-resistant Enterobacterales (CRE) and Acinetobacter baumannii, are included in the 2024 list of high-priority antibiotic-resistant bacterial pathogens that pose the greatest threat to public health. Gram-negative bacteria are also implicated in the development of hospital-acquired infections (HAIs).
In this Special Issue, we invite the submission of publications on the latest research regarding:
- Epidemiological trends in AMR, with a focus on multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) strains of Gram-negative bacteria.
- Molecular mechanisms of antimicrobial resistance in Gram-negative bacteria and therapeutic options for these infections.
- Applications of novel diagnosis and detection methods of the resistance phenotypes of these high-priority pathogens.
- Prevention and control strategies used to fight antimicrobial resistance and the relative impact seen on antimicrobial resistance.
We welcome original research articles, comprehensive reviews, or meta-analyses.
Prof. Maria Balasoiu
Dr. Andreea-Loredana Golli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- gram-negative bacterial infections
- pathogens
- Acinetobacter baumannii
- hospital-acquired infections
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

